Maimah Karmo, founder and CEO of Tigerlily Foundation, talks about Tigerlily Foundation’s partnership with GSK, Living Legacy and pharma accountability in ensuring breast cancer clinical trial access to underrepresented communities.
The Tigerlily Foundation has launched national and global efforts focused on ending disparities, most recently the My Living Legacy Campaign, supported by GSK, which aims to educate and empower Black and BIPOC communities on the potential benefits of clinical trials and provide culturally relevant, health-literacy-focused materials to start conversations among communities.